Is YVR or MRK a better dividend investment in 2026?

YVR currently yields 465.12% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: YVR offers higher current income.

What is the dividend yield difference between YVR and MRK?

YVR has a forward dividend yield of 465.12% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 462.36 percentage points.

Home › Compare › YVR vs MRK

YVR vs MRK: Dividend Comparison 2026

YVR yields 465.12% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 YVR wins by $35260.42M in total portfolio value

INVESTMENT

TIME HORIZON10 years

YVR

● Live price

465.12%

Share price

$0.43

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$35260.48M

Annual income

$24,780,059,848.68

Full YVR calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — YVR vs MRK

📍 YVR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	YVR	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, YVR + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

YVR pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

YVR

Annual income on $10K today (after 15% tax)

$39,534.88/yr

After 10yr DRIP, annual income (after tax)

$21,063,050,871.38/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, YVR beats the other by $21,063,042,542.97/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of YVR + MRK for your $10,000?

YVR: 50%MRK: 50%

100% MRK50/50100% YVR

Portfolio after 10yr

$17630.27M

Annual income

$12,390,034,823.41/yr

Blended yield

70.28%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

YVR

No analyst data

Altman Z

0.0

Piotroski

7/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

YVR buys

MRK buys

No recent congressional trades found for YVR or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricYVRMRK

Forward yield	465.12% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$35260.48M ✓	$56.8K
Annual income after 10y	$24,780,059,848.68 ✓	$9,798.13
Total dividends collected	$34333.38M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: YVR vs MRK ($10,000, DRIP)

Year	YVR Portfolio	YVR Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$57,212	$46,511.63	$11,206	$366.19	+$46.0K → YVR
2	$309,909	$248,692.14	$12,650	$502.35	+$297.3K → YVR
3	$1,590,608	$1,259,005.40	$14,407	$694.19	+$1.58M → YVR
4	$7,741,065	$6,039,114.42	$16,585	$967.82	+$7.72M → YVR
5	$35,750,944	$27,468,005.00	$19,342	$1,363.89	+$35.73M → YVR
6	$156,811,320	$118,557,809.37	$22,913	$1,947.19	+$156.79M → YVR
7	$653,788,128	$486,000,015.63	$27,662	$2,823.89	+$653.76M → YVR
8	$2,593,257,425	$1,893,704,128.62	$34,159	$4,173.35	+$2593.22M → YVR
9	$9,794,782,802	$7,019,997,357.51	$43,337	$6,308.80	+$9794.74M → YVR
10	$35,260,477,447	$24,780,059,848.68	$56,776	$9,798.13	+$35260.42M → YVR

YVR vs MRK: Complete Analysis 2026

YVR — Stock

Liquid Media Group Ltd. provides business solutions empowering independent TV and content creators to package, finance, deliver, and monetize their intellectual property worldwide. The company makes and distributes social impact-based film programming and curriculum to various audiences and markets through subscription-based video-on-demand streaming service. It also operates an online video community that provides filmmakers to self-distribute content directly to their viewers; and a comprehensive content recommendation platform that helps audiences discover engaging movies, TV series, and TV programs to watch. The company has a strategic partnership with Slated, Inc. Liquid Media Group Ltd. is headquartered in Vancouver, Canada.

Full YVR Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this YVR vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

YVR vs SCHD YVR vs JEPI YVR vs O YVR vs KO YVR vs MAIN YVR vs JNJ YVR vs ABBV YVR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.